Skip to main content
logo
Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
45.71
-5.58 (-10.88%)
At close: Nov 5, 2026, 4:00 PM EST
41.74
-3.97 (-8.69%)
Pre-market: Nov 6, 2026, 4:24 AM EST

Rigel Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
307.19367.0217.49-25.09-58.57-17.91
Depreciation & Amortization
3.842.422.231.2411.16
Loss (Gain) From Sale of Assets
---0.080.27-0.14-
Loss (Gain) From Sale of Investments
-0.48-1.15-0.71-0.48-0.060.29
Stock-Based Compensation
17.912.7112.398.8112.399.49
Other Operating Activities
-234.32-285.83--0.683.14
Change in Accounts Receivable
-10.53-10.15-11.079.77-24.850.5
Change in Inventory
-6.89-5.640.761.17-2.38-4.88
Change in Accounts Payable
5.13.85-3.8-0.373.790.04
Change in Unearned Revenue
-----1.23-0.42
Change in Other Net Operating Assets
8.11-7.5814.26-1.06-4.3914.47
Operating Cash Flow
89.9275.6631.47-5.74-73.765.88
Operating Cash Flow Growth
31.89%140.40%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
0.01--0.04--0.45-0.63
Sale of Property, Plant & Equipment
--0.10.260.89-
Sale (Purchase) of Intangibles
-70.56--0.36-15--
Investment in Securities
36.22-92.374.4310.4472.33-79.41
Investing Cash Flow
-34.33-92.374.13-4.372.78-80.04

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---19.9519.54-
Long-Term Debt Repaid
--7.5----
Net Debt Issued (Repaid)
-54.75-7.5-19.9519.54-
Issuance of Common Stock
7.898.11.961.052.1262.68
Other Financing Activities
-5.35--13.61-2.63-15.12-
Financing Cash Flow
-57.480.6-11.6418.376.5562.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-1.89-16.1123.968.335.57-11.48

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
89.9375.6631.44-5.74-74.215.25
Free Cash Flow Growth
31.98%140.67%----
Free Cash Flow Margin
31.20%25.71%17.53%-4.91%-64.11%3.79%
Free Cash Flow Per Share
4.504.021.78-0.33-4.350.31
Levered Free Cash Flow
-13.7774.6122.99-25.13-39.8310.44
Unlevered Free Cash Flow
-11.1779.1827.93-20.84-37.5213.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
6.746.577.045.852.51.5
Cash Income Tax Paid
1.061.060.330.08--
Change in Working Capital
-4.21-19.510.159.52-29.059.72
SEC Filings: 10-K · 10-Q